Huebner, Kerstin
Erlenbach-Wuensch, Katharina
Prochazka, Jan
Sheraj, Ilir
Hampel, Chuanpit
Mrazkova, Blanka
Michalcikova, Tereza
Tureckova, Jolana
Iatsiuk, Veronika
Weissmann, Anne
Ferrazzi, Fulvia
Kunze, Philipp
Nalli, Enise
Sammer, Elisabeth
Gehring, Annemarie
Cheema, Marie M.
Eckstein, Markus
Paap, Eva-Maria
Soederberg, Agnes
Fischer, Corinna
Paul, Sushmita
Mahadevan, Vijayalakshmi
Ndreshkjana, Benardina
Meier, Melanie A.
Muehlich, Susanne
Geppert, Carol I.
Merkel, Susanne
Grutzmann, Robert
Roehe, Adriana
Banerjee, Sreeparna
Hartmann, Arndt
Sedlacek, Radislav
Schneider-Stock, Regine http://orcid.org/0000-0003-0482-531X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SCHN477/18-1)
European Cooperation in Science and Technology (CA17118)
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences (LM2015040, RVO 68378050)
Univerzita Karlova v Praze (Z.1.05/1.1.00/02.0109)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 12 April 2022
Revised: 21 June 2022
Accepted: 23 June 2022
First Online: 15 July 2022
Declarations
:
: The authors declare no direct conflicts of interest regarding the present study. No funding from commercial sources has been obtained for the present study. Besides this, the following authors have financial relations to disclose: M. Eckstein received speaker’s bureau honoraria from Janssen, Roche, Astellas, Diaceutics, MSD, AstraZeneca; grant support from AstraZeneca, Janssen, STRATIFYER, and Diaceutics; advisory honoraria and personal fees from Diaceutics, AstraZeneca, GenomicHealth, and Janssen. A. Hartmann reports receiving a commercial research grant from BioNTech, Cepheid, Janssen, and Roche, has received speakers’ bureau honoraria from BMS, MSD, Roche, AbbVie, Boehringer Ingelheim, AstraZeneca, Novartis, Janssen, Cepheid, and NanoString, and has provided expert testimony for Prosigna. C. I. Geppert received personal fees and speakers’ bureau honoraria from Sysmex and Roche.
: This study was covered by ethic votes of the University Hospital of the Friedrich-Alexander University Erlangen-Nürnberg (24.01.2005, 18.01.2012). All performed procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All mouse experiments including breeding and housing were performed in accordance with the institutional guidelines of the University Erlangen-Nuremberg and of the Institute of Molecular Genetics, Czech Academy of Science, Prague.